TLDR: Injective price slips below $15 after recent breakout, raising questions about short-term momentum. $13.95–$14.20 zone may act as a critical retest area for …
The Chicago Board Options Exchange (Cboe) filed to list shares of Canary Capital’s proposed staked Injective exchange-traded fund (ETF), further expanding the wave of …